Clinical Trials Directory

Trials / Completed

CompletedNCT00905580

Perioperative Administration of Pregabalin for Pain After Robot-assisted Endoscopic Thyroidectomy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
99 (actual)
Sponsor
Severance Hospital · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesize that pregabalin will decrease post-operative pain scores and analgesic use following robot-assisted endoscopic thyroidectomy compared to placebo. The primary outcome will be acute postoperative pain, measured by a verbal numerical rating score (VNRS) and total analgesic consumption during postoperative 48 hours. The secondary outcome will be the incidence of chronic pain and hypoesthesia in the anterior chest at 3 months after operation.

Conditions

Interventions

TypeNameDescription
DRUGPregabalinPregabalin 150 mg orally
DRUGVitamin Complex (placebo)Vitamin Complex 150 mg orally

Timeline

Start date
2009-05-01
Primary completion
2009-09-01
Completion
2009-09-01
First posted
2009-05-20
Last updated
2010-01-20
Results posted
2010-01-11

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00905580. Inclusion in this directory is not an endorsement.